Most Recent
A subsidiary of Coca Cola has won its bid for removal of Sunraysia Natural Beverages' Honest Kids trade mark for non-use, with IP Australia finding only "minimal and isolated" uses of the disputed mark.
In its opening submissions in a trade mark case brought by Botox maker Allergan, Australian cosmetics brand Self Care compared its used of the word Botox to describe its alternative cosmetic products to the iPhone secondary accessories market, saying its use did not imply an affiliation with the injectable wrinkle treatment's maker.
A case simultaneously challenging IP Australia's decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product companies has been withdrawn, a court has heard.
The battle to acquire IP services company Xenith IP Group is set to intensify after the Australian Competition and Consumer Commission blessed a hostile offer by IPH Limited.
The Australian Competition and Consumer Commission will not oppose the merger of two companies that own some of Australia's largest intellectual property boutiques.
An eight-day joint hearing in cases brought by Allergan alleging infringement of its Botox trade mark, which was due to commence Monday, has been unexpectedly vacated by the court, with barristers and legal teams left in the dark about the reasons.
Chemical giant BASF is appealing an IP Australia ruling that allowed US-based Lubrizol Corporation to amend certain claims of its patent for an improved fuel additive.
Pharmaceutical giant Allergan has streamlined its trade mark case against Self Care Corporation, which makes products marketed as Botox alternatives.
Canadian generic manufacturer Apotex has agreed to drop its lawsuit against India's Cipla seeking to invalidate its Australian patent for popular nasal spray Dymista.
The Commissioner of Patents will seek to toss a case simultaneously challenging its decisions to accept, grant and certify an innovation patent owned by one of Australia's biggest building product firms.